Business Standard

Kilitch Drugs (India) standalone net profit rises 395.65% in the March 2018 quarter

Image

Capital Market

Sales rise 87.35% to Rs 15.70 crore

Net profit of Kilitch Drugs (India) rose 395.65% to Rs 2.28 crore in the quarter ended March 2018 as against Rs 0.46 crore during the previous quarter ended March 2017. Sales rose 87.35% to Rs 15.70 crore in the quarter ended March 2018 as against Rs 8.38 crore during the previous quarter ended March 2017.

For the full year,net profit reported to Rs 6.20 crore in the year ended March 2018 as against net loss of Rs 0.04 crore during the previous year ended March 2017. Sales rose 79.32% to Rs 50.46 crore in the year ended March 2018 as against Rs 28.14 crore during the previous year ended March 2017.

 
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales15.708.38 87 50.4628.14 79 OPM %15.2910.02 -11.04-1.00 - PBDT3.361.24 171 8.350.86 871 PBT3.050.90 239 7.16-0.46 LP NP2.280.46 396 6.20-0.04 LP

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 26 2018 | 5:50 PM IST

Explore News